144 related articles for article (PubMed ID: 3422447)
1. Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells.
Scanlon KJ; Kashani-Sabet M
Proc Natl Acad Sci U S A; 1988 Feb; 85(3):650-3. PubMed ID: 3422447
[TBL] [Abstract][Full Text] [Related]
2. Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells.
Marverti G; Ligabue A; Paglietti G; Corona P; Piras S; Vitale G; Guerrieri D; Luciani R; Costi MP; Frassineti C; Moruzzi MS
Eur J Pharmacol; 2009 Aug; 615(1-3):17-26. PubMed ID: 19446547
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cross-resistance to methotrexate and 5-fluorouracil in an A2780 human ovarian carcinoma cell subline resistant to cisplatin.
Newman EM; Lu Y; Kashani-Sabet M; Kesavan V; Scanlon KJ
Biochem Pharmacol; 1988 Feb; 37(3):443-7. PubMed ID: 3337743
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acid.
Lu Y; Han J; Scanlon KJ
J Biol Chem; 1988 Apr; 263(10):4891-4. PubMed ID: 3258308
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells.
Marverti G; Ligabue A; Lombardi P; Ferrari S; Monti MG; Frassineti C; Costi MP
Int J Oncol; 2013 Oct; 43(4):1269-80. PubMed ID: 23903781
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
Dempke WC; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Hill BT
Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms for cisplatin-FUra synergism and cisplatin resistance in human ovarian carcinoma cells both in vitro and in vivo.
Scanlon KJ; Lu Y; Kashani-Sabet M; Ma J; Newman E
Adv Exp Med Biol; 1988; 244():127-35. PubMed ID: 3247881
[TBL] [Abstract][Full Text] [Related]
8. Analysis of thymidylate synthase gene amplification and of mRNA levels in the cell cycle.
Imam AM; Crossley PH; Jackman AL; Little PF
J Biol Chem; 1987 May; 262(15):7368-73. PubMed ID: 3584117
[TBL] [Abstract][Full Text] [Related]
9. Induction of thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma cell line.
Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K
Anticancer Res; 2003; 23(2B):1525-31. PubMed ID: 12820419
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacity.
Taverna P; Hansson J; Scanlon KJ; Hill BT
Carcinogenesis; 1994 Sep; 15(9):2053-6. PubMed ID: 7923602
[TBL] [Abstract][Full Text] [Related]
11. Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells.
Miyachi H; Jiao L; Sowers LC; Scanlon KJ
In Vivo; 1992; 6(1):17-21. PubMed ID: 1385729
[TBL] [Abstract][Full Text] [Related]
12. Establishment of pemetrexed-resistant non-small cell lung cancer cell lines.
Zhang D; Ochi N; Takigawa N; Tanimoto Y; Chen Y; Ichihara E; Hotta K; Tabata M; Tanimoto M; Kiura K
Cancer Lett; 2011 Oct; 309(2):228-35. PubMed ID: 21742432
[TBL] [Abstract][Full Text] [Related]
13. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.
Foote SJ; Galatis D; Cowman AF
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3014-7. PubMed ID: 2183221
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine.
Scanlon KJ; Kashani-Sabet M; Sowers LC
Cancer Commun; 1989; 1(4):269-75. PubMed ID: 2534792
[TBL] [Abstract][Full Text] [Related]
15. Expression of collateral sensitivity to cisplatin, methotrexate, and fluorouracil in a human ovarian carcinoma cell line following exposure to fractionated x-irradiation in vitro.
Dempke WC; Hosking LK; Hill BT
Semin Oncol; 1992 Apr; 19(2 Suppl 3):66-72. PubMed ID: 1557659
[TBL] [Abstract][Full Text] [Related]
16. Expression of rTS correlates with altered growth regulation of thymidylate synthase.
Black AR; Dolnick BJ
Cancer Res; 1996 Feb; 56(4):700-5. PubMed ID: 8630998
[TBL] [Abstract][Full Text] [Related]
17. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
FitzGerald GB; Wick MM
Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
[TBL] [Abstract][Full Text] [Related]
18. The role of expression of the components of proteome in the formation of molecular profile of human ovarian carcinoma A2780 cells sensitive and resistant to cisplatin.
Chekhun VF; Lukyanova NY; Urchenko OV; Kulik GI
Exp Oncol; 2005 Sep; 27(3):191-5. PubMed ID: 16244579
[TBL] [Abstract][Full Text] [Related]
19. Appearance of amplified thymidylate synthase or dihydrofolate reductase genes in stage-IV breast-cancer patients receiving endocrine treatment.
Lönn U; Lönn S; Stenkvist B
Int J Cancer; 1993 May; 54(2):237-42. PubMed ID: 8486425
[TBL] [Abstract][Full Text] [Related]
20. Addendum to "Trypanosoma brucei dihydrofolate reductase-thymidylate synthase: gene isolation and expression and characterization of the enzyme" [Mol. Biochem. Parasitol. 72 (1995) 11-22].
Gamarro F; Yu PL; Zhao J; Edman U; Greene PJ; Santi D
Mol Biochem Parasitol; 1995 Dec; 75(1):127. PubMed ID: 8720183
[No Abstract] [Full Text] [Related]
[Next] [New Search]